Fact checked by Nick Blackmer Compounded versions of semaglutide, the active ingredient in weight loss drugs like Ozempic and ...

On Tuesday, regulators with the US Food and Drug Administration (FDA) approved Johnson ... most important discovery in half a century." The list price of the new drug ranges from $590 to $ ...

Under the Biden administration proposal unveiled last November, an estimated 3.4 million Americans on Medicare would be eligible in 2026 for the drugs, which carry a list price of more than $1,000 a ...

Each drug is also approved ... called glucagon-like peptide-1 receptor agonists. They work in similar ways when used by people with a condition that both drugs are approved to help treat.

The Sanofi drug, known as fitusiran and now Qfitlia, was approved on Friday for a broad group of people with the rare bleeding disorder.

Glucagon-like peptide-1 agonists, a class of medications known as GLP-1s, have grown in popularity, initially for the treatment of type 2 diabetes ...

The U.S. Food and Drug Administration on Wednesday approved Soleno Therapeutics' drug to treat a rare genetic disorder, ...